Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...
Clinical Trials Arena on MSN
InnoCare’s BTK inhibitor advances to Phase III in SLE
Within the 48-week treatment window, the Bruton’s tyrosine kinase (BTK) inhibitor triggered a 57.1% improvement in patients’ ...
Colombia and Brazil had the highest prevalence and incidence of systemic lupus erythematosus (SLE), a new investigation found. A new analysis of low- and middle-income countries suggests that cases of ...
Orelabrutinib demonstrated outstanding efficacy and well-tolerated safety profile in patients with SLE who had received 48 weeks of treatment in the phase IIb study. A total of 187 patients were ...
Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, ...
While the hallways of the Cardenal dorm of Florence Moore Hall are often filled with laughter and hustles, they also often host hours-long deep intellectual conversations about — among other typical ...
Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE
Objective Delivery of a small for gestational age (SGA) infant is a common pregnancy complication among women with SLE.
A new study outlining the experiences of women with systemic lupus erythematosus (SLE) finds many women feel their initial symptoms are downplayed by providers, leading to costly delays in diagnosis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback